An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Journal article |
Publicado: |
2013
|
Summary: |
---|